Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma.
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, Stephen M Broski, Jose C Villasboas, Jonas Paludo, Mrinal Patnaik, Vincent Rajkumar, Angela Dispenzieri, Nelson Leung, Francis Buadi, Nora Bennani, Stephen M Ansell, Lianwen Zhang, Nandakumar Packiriswamy, Baskar Balakrishnan, Bethany Brunton, Marissa Giers, Brenda Ginos, Amylou C Dueck, Susan Geyer, Morie A Gertz, Rahma Warsame, Ronald S Go, Suzanne R Hayman, David Dingli, Shaji Kumar, Leif Bergsagel, Javier L Munoz, Wilson Gonsalves, Taxiarchis Kourelis, Eli Muchtar, Prashant Kapoor, Robert A Kyle, Yi Lin, Mustaqeem Siddiqui, Amie Fonder, Miriam Hobbs, Lisa Hwa, Shruthi Naik, Stephen J Russell, Martha Q Lacy
Blood advances 2022;6(11):3268-3279